从1990年到2024年对药物特异性免疫疗法的图书统计和视觉分析
Zhengjiu Cui1, Xiaorui Chen1, Siming Zhai1
1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Naunyn-Schmiedeberg's archives of pharmacology
|March 25, 2025
概括
本文献分析回顾了药物特异性免疫疗法 (SIT) 研究,强调了其增长和主要贡献者. 它确定与瘤相关的SIT和药物机制是目前的研究前沿,用于未来的进展.
科学领域:
- 免疫学和药理学
- 图书统计分析 图书统计分析
- 过敏性疾病和自身免疫调节
背景情况:
- 特定免疫疗法 (SIT) 对过敏性疾病,瘤免疫和自身免疫调节至关重要.
- 了解SIT中的药物机制,包括过敏和免疫耐受性,提出了持续的科学挑战.
- 累积的研究需要进行文献计量审查,以指导药理学SIT的未来学术发展.
研究的目的:
- 进行药物特异性免疫疗法 (SIT) 研究的文献分析.
- 识别出版趋势,主要贡献者,有影响力的期刊和研究热点.
- 为未来的研究方向和药物SIT的优化策略提供见解.
主要方法:
- 在Web of Science核心集合中使用严格标准进行文献搜索.
- 使用Citespace,VOSviewer和Bibliometrix对682个出版物的分析和可视化.
- 审查出版趋势,作者贡献,机构合作和关键词分析.
主要成果:
- 毒品SIT出版物的显著增长趋势,引用在1998年达到顶峰.
- 美国和热那亚大学在出版物方面处于领先地位;克里斯托福罗·恩科瓦亚和J Bousquet是主要作者.
- 过敏和过敏和临床免疫学杂志是领先的期刊;与瘤相关的SIT和药物机制是关键研究领域.
结论:
- 药物SIT研究在全球范围内取得进展,但需要加强国际合作.
- 确定研究热点和尖端主题将指导未来的突破.
- 对药物SIT机制和应用的进一步研究对人类健康和安全至关重要.
相关概念视频
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


